Cargando…
Phase I dose-escalation, safety, and CNS pharmacokinetic study of dexanabinol in patients with brain cancer
BACKGROUND: Dexanabinol is a synthetic analogue of tetrahydrocannabinol identified as a potential anti-cancer therapeutic by e-Therapeutics PLC. Dexanabinol was selected for further investigation based on its preclinical tumoricidal activity. This phase I dose-escalation trial examined the safety, d...
Autores principales: | Juarez, Tiffany M, Piccioni, David, Rose, Lara, Nguyen, Angel, Brown, Bradley, Kesari, Santosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883766/ https://www.ncbi.nlm.nih.gov/pubmed/33615223 http://dx.doi.org/10.1093/noajnl/vdab006 |
Ejemplares similares
-
Solid lipid nanoparticles loading with curcumin and dexanabinol to treat major depressive disorder
por: He, Xiao-Lie, et al.
Publicado: (2020) -
Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study
por: Sarantopoulos, John, et al.
Publicado: (2017) -
Open‐Label, Dose‐Escalation, Phase 1 Study of Safety and Single and Multiple‐Dose Pharmacokinetics of Dichlorphenamide in Healthy Volunteers
por: Cohen, Fredric
Publicado: (2018) -
Phase 1 Dose‐Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Japanese Healthy Volunteers
por: Miyoshi, So, et al.
Publicado: (2019) -
Effects of Mesenchymal Stem Cell Treatment on Systemic Cytokine Levels in a Phase 1 Dose Escalation Safety Trial of Septic Shock Patients*
por: Schlosser, Kenny, et al.
Publicado: (2019)